Bodycote plc (BOY) Ordinary 17 3/11p

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
Tuesday broker round-up
9 February 2021 13:46
(Sharecast News) - Spirent Communications: Canaccord upgrades to buy with a target price of 275p.
-
Friday broker round-up
15 January 2021 13:05
(Sharecast News) - BT: UBS downgrades to sell with a target price of 111p.
-
Monday broker round-up
30 November 2020 13:40
(Sharecast News) - Bodycote: JP Morgan downgrades to underweight with a target price of 635p.
-
JPMorgan downgrades Bodycote, cites near-term pressures
30 November 2020 08:25
(Sharecast News) - JPMorgan Cazenove downgraded heat treatments supplier Bodycote on Monday to 'underweight' from 'neutral' and cut the price target 635p from 670p as it argued that...
-
Bodycote announces another restructuring, shares slide
26 November 2020 09:25
(Sharecast News) - Bodycote shares slid on Thursday after the heat treatment and thermal processing company announced another restructuring and sounded a downbeat note on the outlook for the civil aerospace...
-
Bodycote permanently slashes costs amid Covid downturn
23 July 2020 10:28
(Sharecast News) - Bodycote said on Thursday that its first half was "significantly impacted" by the Covid-19 downturn, reporting a 16.6% fall in revenue at constant currency to £306.7m.
-
Thursday broker round-up
4 June 2020 14:03
(Sharecast News) - IWG: RBC Capital Markets downgrades to sector performer with a target price of 325p.
-
Bodycote cuts more than 700 jobs after revenue slumps
28 May 2020 07:39
(Sharecast News) - Bodycote is cutting more than 700 jobs and closing factories after underlying revenue fell by more than a third in April because of the Covid-19 shutdown.
-
Bodycote defers dividend decision due to Covid-19
23 April 2020 08:02
(Sharecast News) - Bodycote said on Thursday that it will defer a decision on its 2019 dividend until there is more clarity on the impact of the coronavirus pandemic.
-
Bodycote Q1 not 'significantly' impacted by Covid-19; final divi under review
6 April 2020 07:44
(Sharecast News) - Bodycote said on Monday that first-quarter trading has not been "significantly" impacted by the Covid-19 pandemic but that its proposed final dividend is under review given...
-
Bodycote could do well in 2021 recovery, JP Morgan says
25 March 2020 14:28
(Sharecast News) - Bodycote is in a position to do well in a recovery from the Covid-19 crisis, JP Morgan said as it upgraded the company's shares to 'neutral'.
-
Bodycote profits down amid 'tough' market conditions
12 March 2020 08:47
(Sharecast News) - Bodycote reported a 1.2% fall in revenue in its full-year results on Thursday, to ?719.7m, or a 2% decline at constant currency.
Company announcements Announcements
-
Holding(s) in Company
4 March 2021 10:06
Bodycote
-
Total Voting Rights
1 March 2021 07:00
Bodycote
-
Appointment of Joint Corporate Broker
18 February 2021 07:00
Bodycote
-
Holding(s) in Company
5 February 2021 14:44
Bodycote
-
Total Voting Rights
29 January 2021 17:02
Bodycote
-
Total Voting Rights
30 December 2020 17:01
Bodycote
-
Holding(s) in Company
16 December 2020 16:58
Bodycote
-
Holding(s) in Company
10 December 2020 13:36
Bodycote
-
Holding(s) in Company
9 December 2020 14:26
Bodycote
-
Total Voting Rights
30 November 2020 17:02
Bodycote
-
Holding(s) in Company
27 November 2020 13:09
Bodycote
-
Trading Update
26 November 2020 07:00
Bodycote
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.